174 related articles for article (PubMed ID: 37738546)
1. Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer.
Sia TY; Maio A; Kemel YM; Arora KS; Gordhandas SB; Kahn RM; Salo-Mullen EE; Sheehan MA; Tejada PR; Bandlamudi C; Zhou Q; Iasonos A; Grisham RN; O'Cearbhaill RE; Tew WP; Long Roche K; Zivanovic O; Sonoda Y; Gardner GJ; Chi DS; Latham AJ; Carlo MI; Murciano-Goroff YR; Will M; Walsh MF; Robson ME; Mandelker DL; Berger MF; Abu-Rustum NR; Brown CL; Offit K; Hamilton JG; Aghajanian C; Weigelt B; Stadler ZK; Liu YL
JCO Precis Oncol; 2023 Sep; 7():e2300137. PubMed ID: 37738546
[TBL] [Abstract][Full Text] [Related]
2. Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants.
Liu YL; Maio A; Kemel Y; Salo-Mullen EE; Sheehan M; Tejada PR; Trottier M; Arnold AG; Fleischut MH; Latham A; Carlo MI; Murciano-Goroff YR; Walsh MF; Mandelker D; Mehta N; Bandlamudi C; Arora K; Zehir A; Berger MF; Solit DB; Aghajanian C; Diaz LA; Robson ME; Brown CL; Offit K; Hamilton JG; Stadler ZK
Cancer; 2022 Nov; 128(21):3870-3879. PubMed ID: 36041233
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic germline variants in patients with endometrial cancer of diverse ancestry.
Liu YL; Gordhandas S; Arora K; Rios-Doria E; Cadoo KA; Catchings A; Maio A; Kemel Y; Sheehan M; Salo-Mullen E; Zhou Q; Iasonos A; Carrot-Zhang J; Manning-Geist B; Sia TY; Selenica P; Vanderbilt C; Misyura M; Latham A; Bandlamudi C; Berger MF; Hamilton JG; Makker V; Abu-Rustum NR; Ellenson LH; Offit K; Mandelker DL; Stadler Z; Weigelt B; Aghajanian C; Brown C
Cancer; 2024 Feb; 130(4):576-587. PubMed ID: 37886874
[TBL] [Abstract][Full Text] [Related]
4. Causality and functional relevance of BRCA1 and BRCA2 pathogenic variants in non-high-grade serous ovarian carcinomas.
Kramer C; Lanjouw L; Ruano D; Ter Elst A; Santandrea G; Solleveld-Westerink N; Werner N; van der Hout AH; de Kroon CD; van Wezel T; Berger L; Jalving M; Wesseling J; Smit V; de Bock GH; van Asperen CJ; Mourits M; Vreeswijk M; Bart J; Bosse T
J Pathol; 2024 Feb; 262(2):137-146. PubMed ID: 37850614
[TBL] [Abstract][Full Text] [Related]
5. Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis.
Witjes VM; van Bommel MHD; Ligtenberg MJL; Vos JR; Mourits MJE; Ausems MGEM; de Hullu JA; Bosse T; Hoogerbrugge N
Gynecol Oncol; 2022 Jan; 164(1):221-230. PubMed ID: 34702566
[TBL] [Abstract][Full Text] [Related]
6. Predicting the likelihood of a
Morgan RD; Burghel GJ; Flaum N; Bulman M; Smith P; Clamp AR; Hasan J; Mitchell C; Salih Z; Woodward ER; Lalloo F; Shaw J; Desai S; Crosbie EJ; Edmondson RJ; Schlecht H; Wallace AJ; Jayson GC; Evans DGR
J Clin Pathol; 2023 Oct; 76(10):684-689. PubMed ID: 35738887
[TBL] [Abstract][Full Text] [Related]
7.
Harriman JW; Espinel WF; Vagher J; Gammon A
JCO Precis Oncol; 2022 Oct; 6():e2100375. PubMed ID: 36201716
[TBL] [Abstract][Full Text] [Related]
8. Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients.
Isiklar AD; Aliyeva L; Yesilyurt A; Soyder A; Basaran G
Breast Cancer Res Treat; 2023 Nov; 202(2):297-304. PubMed ID: 37615792
[TBL] [Abstract][Full Text] [Related]
9. Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019.
Kurian AW; Ward KC; Abrahamse P; Bondarenko I; Hamilton AS; Deapen D; Morrow M; Berek JS; Hofer TP; Katz SJ
J Clin Oncol; 2021 May; 39(15):1631-1640. PubMed ID: 33560870
[TBL] [Abstract][Full Text] [Related]
10. Uptake of testing for germline
Stearnes G; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Cohen PA
Int J Gynecol Cancer; 2019 Jul; 29(6):1038-1042. PubMed ID: 31101686
[TBL] [Abstract][Full Text] [Related]
11. Racial and ethnic variation in BRCA1 and BRCA2 genetic test results among individuals referred for genetic counseling at a large urban comprehensive cancer center.
Abdallah N; Purrington KS; Tatineni S; Assad H; Petrucelli N; Simon MS
Cancer Causes Control; 2023 Feb; 34(2):141-149. PubMed ID: 36370215
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.
Lawrenson K; Song F; Hazelett DJ; Kar SP; Tyrer J; Phelan CM; Corona RI; Rodríguez-Malavé NI; Seo JH; Adler E; Coetzee SG; Segato F; Fonseca MAS; Amos CI; Carney ME; Chenevix-Trench G; Choi J; Doherty JA; Jia W; Jin GJ; Kim BG; Le ND; Lee J; Li L; Lim BK; Adenan NA; Mizuno M; Park B; Pearce CL; Shan K; Shi Y; Shu XO; Sieh W; ; Thompson PJ; Wilkens LR; Wei Q; Woo YL; Yan L; Karlan BY; Freedman ML; Noushmehr H; Goode EL; Berchuck A; Sellers TA; Teo SH; Zheng W; Matsuo K; Park S; Chen K; Pharoah PDP; Gayther SA; Goodman MT
Gynecol Oncol; 2019 May; 153(2):343-355. PubMed ID: 30898391
[TBL] [Abstract][Full Text] [Related]
13. The first Japanese nationwide multicenter study of
Enomoto T; Aoki D; Hattori K; Jinushi M; Kigawa J; Takeshima N; Tsuda H; Watanabe Y; Yoshihara K; Sugiyama T
Int J Gynecol Cancer; 2019 Jul; 29(6):1043-1049. PubMed ID: 31263023
[TBL] [Abstract][Full Text] [Related]
14. High detection rate from genetic testing in BRCA-negative women with familial epithelial ovarian cancer.
Flaum N; Crosbie EJ; Edmondson R; Woodward ER; Lalloo F; Smith MJ; Schlecht H; Evans DG
Genet Med; 2022 Dec; 24(12):2578-2586. PubMed ID: 36169650
[TBL] [Abstract][Full Text] [Related]
15. BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups.
Safra T; Lai WC; Borgato L; Nicoletto MO; Berman T; Reich E; Alvear M; Haviv I; Muggia FM
Ann Oncol; 2013 Nov; 24 Suppl 8():viii63-viii68. PubMed ID: 24131973
[TBL] [Abstract][Full Text] [Related]
16. The Prevent Ovarian Cancer Program (POCP): Identification of women at risk for ovarian cancer using complementary recruitment approaches.
Tone AA; McCuaig JM; Ricker N; Boghosian T; Romagnuolo T; Stickle N; Virtanen C; Zhang T; Kim RH; Ferguson SE; May T; Laframboise S; Armel S; Demsky R; Volenik A; Stuart-McEwan T; Shaw P; Oza A; Kamel-Reid S; Stockley T; Bernardini MQ
Gynecol Oncol; 2021 Jul; 162(1):97-106. PubMed ID: 33858678
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients.
Culver JO; Ricker CN; Bonner J; Kidd J; Sturgeon D; Hodan R; Kingham K; Lowstuter K; Chun NM; Lebensohn AP; Rowe-Teeter C; Levonian P; Partynski K; Lara-Otero K; Hong C; Morales Pichardo J; Mills MA; Brown K; Lerman C; Ladabaum U; McDonnell KJ; Ford JM; Gruber SB; Kurian AW; Idos GE
Cancer; 2021 Apr; 127(8):1275-1285. PubMed ID: 33320347
[TBL] [Abstract][Full Text] [Related]
18. Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Konstantinopoulos PA; Norquist B; Lacchetti C; Armstrong D; Grisham RN; Goodfellow PJ; Kohn EC; Levine DA; Liu JF; Lu KH; Sparacio D; Annunziata CM
J Clin Oncol; 2020 Apr; 38(11):1222-1245. PubMed ID: 31986064
[TBL] [Abstract][Full Text] [Related]
19. Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing.
Tuncer SB; Celik B; Erciyas SK; Erdogan OS; Gültaslar BK; Odemis DA; Avsar M; Sen F; Saip PM; Yazici H
Pathol Res Pract; 2024 Feb; 254():155075. PubMed ID: 38219492
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel epithelial ovarian cancer loci in women of African ancestry.
Manichaikul A; Peres LC; Wang XQ; Barnard ME; Chyn D; Sheng X; Du Z; Tyrer J; Dennis J; Schwartz AG; Cote ML; Peters E; Moorman PG; Bondy M; Barnholtz-Sloan JS; Terry P; Alberg AJ; Bandera EV; Funkhouser E; Wu AH; Pearce CL; Pike M; Setiawan VW; Haiman CA; ; ; Palmer JR; LeMarchand L; Wilkens LR; Berchuck A; Doherty JA; Modugno F; Ness R; Moysich K; Karlan BY; Whittemore AS; McGuire V; Sieh W; Lawrenson K; Gayther S; Sellers TA; Pharoah P; Schildkraut JM;
Int J Cancer; 2020 Jun; 146(11):2987-2998. PubMed ID: 31469419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]